e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Bronchiectasis and NTM infections: clinical and functional characterisation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical utility of serum anti-mycobacterium avium complex (MAC) antibody for diagnosis of MAC lung disease in asymptomatic patients with radiologically suspected MAC lung disease: A pilot study
Naoki Nishimura (Chuo City, Tokyo, Japan), Naoki Nishimura, Hiroshi Nakaoka, Torahiko Jinta, Yutaka Tomishima, Kohei Okafuji, Noboru Uchiyama, Naohiko Chohnabayashi
Source:
International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Session:
Bronchiectasis and NTM infections: clinical and functional characterisation
Session type:
Thematic Poster Session
Number:
2632
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Naoki Nishimura (Chuo City, Tokyo, Japan), Naoki Nishimura, Hiroshi Nakaoka, Torahiko Jinta, Yutaka Tomishima, Kohei Okafuji, Noboru Uchiyama, Naohiko Chohnabayashi. Clinical utility of serum anti-mycobacterium avium complex (MAC) antibody for diagnosis of MAC lung disease in asymptomatic patients with radiologically suspected MAC lung disease: A pilot study. Eur Respir J 2015; 46: Suppl. 59, 2632
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Retrospective investigation of patients positive for glycopeptidolipid-core antibody to mycobacterium avium complex pulmonary disease
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003
Clinical characteristics and outcomes of patients with Mycobacterium avium complex lung disease positive for Aspergillus precipitating antibody
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis
Source: Eur Respir J 2012; 40: 1191-1200
Year: 2012
Characteristics and outcomes of 197 patients newly diagnosed with pulmonary mycobacterium avium complex disease
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
Therapeutic outcomes for cavitary
Mycobacterium avium
complex (MAC) lung disease
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by mycobacterium avium-intracellulare complex (MAC) infection
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003
Usefulness of serum anti-glycopeptidolipid core IgA antibody assay for the diagnosis of pulmonary infection of mycobacterium avium complex
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
Clinical nalysis of glycopeptidolipid core antigen IgA antibodies for cases in which it is difficult to obtain a definite diagnosis of mycobacterium avium complex pulmonary disease
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016
Aspergillus precipitating antibody in patients with Mycobacterium avium complex lung disease; cross-sectional study
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017
Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Characteristics of pulmonary MAC disease diagnosed later in follow-up after negative mycobacterial cultures by bronchoscopy
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Detection of IFN-γ responses for diagnosis of tuberculosis infection in chronic inflammatory disease patients
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Analysis of clinical course after pulmonary resection for
mycobacterium avium
complex lung disease in our hospital
Source: International Congress 2014 – Infection, thoracic trauma and congenital lesions
Year: 2014
Outcome of shorter treatment after culture conversion in non-cavitary MAC lung disease
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Outcomes of
Mycobacterium avium
complex lung disease based on clinical phenotype
Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016
Year: 2017
Long-term follow-up study of patients with pneumoconiosis complicated by nontuberculous mycobacterial lung disease: report of four cases
Source: Eur Respir J 2001; 18: Suppl. 33, 443s
Year: 2001
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept